These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 91081)

  • 1. [Characterization of proteolytic enzyme activities in adenomatous prostatic tissue].
    Blasini R; Stemberger A; Tauber R; Wriedt-Lübbe I; Blümel G
    Med Welt; 1979 Aug; 30(34):1231-2. PubMed ID: 91081
    [No Abstract]   [Full Text] [Related]  

  • 2. A study of proteolytic and fibrinolytic factors in the human prostate.
    Nijs M; Brassinne C; Coune A; Tagnon HJ
    Thromb Diath Haemorrh; 1971 Jun; 25(3):481-98. PubMed ID: 4104828
    [No Abstract]   [Full Text] [Related]  

  • 3. [Demonstration of thymidine phosphorylase activity in human healthy, adenomatous and cancerous prostate].
    Touffet S; Gayet G; Sampérez S; Jouan P
    Bull Cancer; 1992; 79(2):151-9. PubMed ID: 1382732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of thymidine phosphorylase in adenoma and cancer of the human prostate].
    Touffet S; Samperez S; Jouan P
    C R Seances Soc Biol Fil; 1989; 183(1):26-32. PubMed ID: 2476202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arginase activity in prostatic tissue of patients with benign prostatic hyperplasia and prostatic carcinoma.
    Harris BE; Pretlow TP; Bradley EL; Whitehurst GB; Pretlow TG
    Cancer Res; 1983 Jun; 43(6):3008-12. PubMed ID: 6189588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostatic hexosaminidase activity in patients with benign prostatic hyperplasia and prostatic carcinoma.
    Whitehurst GB; Mashburn JP; Pretlow TG; Bradley EL; Boohaker EA
    Cancer Res; 1982 Oct; 42(10):4300-3. PubMed ID: 6179600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactate dehydrogenase isoenzymes in benign and malignant prostatic tissues.
    Mazzuca A; Lalanne GM
    Boll Soc Ital Biol Sper; 1980 Apr; 56(7):690-2. PubMed ID: 6160867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histochemical findings of fibrinolytic activities in the prostatic gland.
    Sugiura H; Shimaya M
    Invest Urol; 1970 Sep; 8(2):188-94. PubMed ID: 4099868
    [No Abstract]   [Full Text] [Related]  

  • 9. Expression of human prostatic acid phosphatase and prostate specific antigen genes in neoplastic and benign tissues.
    Sharief FS; Mohler JL; Sharief Y; Li SS
    Biochem Mol Biol Int; 1994 Jun; 33(3):567-74. PubMed ID: 7524903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on prostatic phosphatase. II. Study on serum acid phosphatase].
    Nakano S
    Hinyokika Kiyo; 1969 Aug; 15(8):565-75. PubMed ID: 4186705
    [No Abstract]   [Full Text] [Related]  

  • 11. Leucine-arylamidase activity in untreated and treated benign prostatic hypertrophy and adenocarcinomatous prostate.
    Verlooy J; van Sande M; Van Camp K
    Acta Urol Belg; 1981 Oct; 49(4):491-5. PubMed ID: 6172970
    [No Abstract]   [Full Text] [Related]  

  • 12. Selectivity of finasteride as an in vivo inhibitor of 5alpha-reductase isozyme enzymatic activity in the human prostate.
    Span PN; Völler MC; Smals AG; Sweep FG; Schalken JA; Feneley MR; Kirby RS
    J Urol; 1999 Jan; 161(1):332-7. PubMed ID: 10037433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of serum lactate dehydrogenase, phosphohexose isomerase, aldolase and hexokinase in prostatic carcinoma.
    Yeshowardhana
    Indian J Physiol Pharmacol; 1985; 29(1):33-8. PubMed ID: 2414222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial characterization of stromal and epithelial forms of 5 alpha-reductase in human prostate.
    Bruchovsky N; McLoughlin MG; Rennie PS; To MP
    Prog Clin Biol Res; 1981; 75A():161-75. PubMed ID: 6175974
    [No Abstract]   [Full Text] [Related]  

  • 15. [Expression and significance of caspase-1 in benign hyperplastic prostate tissues].
    Deng CH; Zang ZJ; Sun XZ; Huang XH; Wang H; Wang D; Su SH
    Zhonghua Nan Ke Xue; 2005 Nov; 11(11):810-2. PubMed ID: 16333955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of dipeptidylpeptidase iv activities in the prostate peripheral zone and prostatic secretions of men with prostate cancer: possible prostate cancer disease marker.
    Wilson MJ; Haller R; Li SY; Slaton JW; Sinha AA; Wasserman NF
    J Urol; 2005 Sep; 174(3):1124-8. PubMed ID: 16094078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostatic acid phosphatase and prostate-specific antigen in prostate cancer.
    Kuriyama M; Loor R; Wang MC; Lee C; Killian CS; Papsidero LD; Inaji H; Nishiura T; Slack NH; Murphy GP; Chu TM
    Int Adv Surg Oncol; 1982; 5():29-49. PubMed ID: 6178696
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical evaluation and measurement of plasma prostatic acid phosphatase by solid phase enzyme immunoassay].
    Okabe H; Noma A; Nakauchi K; Mori M
    Rinsho Byori; 1986 Jul; 34(7):805-10. PubMed ID: 2428995
    [No Abstract]   [Full Text] [Related]  

  • 19. Type IV collagenase (M(r) 72,000) expression in human prostate: benign and malignant tissue.
    Stearns ME; Wang M
    Cancer Res; 1993 Feb; 53(4):878-83. PubMed ID: 7679051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of prostate massage on the levels of prostate acid phosphatase in the serum and urine].
    Wadström J; Huber PR; Scholer A; Rutishauser G
    Helv Chir Acta; 1984 Oct; 51(3-4):437-40. PubMed ID: 6209244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.